Nevoid Basal Cell Carcinomas in Gorlin Syndrome

计划入组 10 人 · 首次发布于 2023 年 6 月 12 日

Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin Syndrome

计划入组 113 人 · 首次发布于 2023 年 9 月 22 日

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

计划入组 107 人 · 首次发布于 2020 年 3 月 16 日

Perflubron Emulsion(Alliance)

InhA inhibitors (GlaxoSmithKline/The Global Alliance for TB Drug Development)

AN-12855

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

Medicus Pharma Partners with Gorlin Syndrome Alliance to Advance Compassionate Access for SKINJECT™ Microneedle Therapy

Medicus Pharma Seeks Orphan Drug Designation for SkinJect in Rare Gorlin Syndrome

Inhibitor Therapeutics Advances Itraconazole for Gorlin Syndrome, Reports 0.265 New Surgically Eligible BCCs Per Patient-Year